Parkinson's disease may be treatable with two existing antimalaria drugs

An estimated 10 million people worldwide are living with Parkinson's disease, a progressive, neurological disorder that mostly strikes after middle age. The team screened around 1,000 drugs already approved by the Food and Drug Administration (FDA) and found two antimalaria drugs - chloroquine and amodiaquine - that boost both protective effects of Nurr1. The team is already looking for other drugs that may halt or reverse the progress of Parkinson's disease, and they plan to improve the drug design and carry out clinical trials of chloroquine and amodiaquine for treating Parkinson's disease.
Read more: Medical News Today

Raspberries have shown a positive correlation between intake of flavonoids in berries and memory improvement, Strict 600 calorie-a-day diet reverses Type 2 diabetes in a week, Babies should exercise, to avoid obesity later in life, Can binge eating cured by a supplement of oestrogen?, The benefits of banana fruit for the body and mind, Simple ways that you can go about reducing your calorie intake, The risk of wear bra throughout the day, The best types of diet to lose 20 pounds in 5 weeks, Metformin for Pre diabetes? Think again, Diseases of children due to animal husbandry,